04/26/2024
4:15 PM | Biogen (Filer)
| Form ARS | |
04/24/2024
3:15 PM | Biogen (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:02 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
4:01 PM | Biogen (Filer)
| Form PRE 14A | |
04/03/2024
7:24 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:11 PM | Biogen (Issuer)
Murphy Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
9:08 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/26/2024
6:54 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
9:12 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:31 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:33 PM | Biogen (Issuer)
Izzar Rachid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:36 PM | Biogen (Issuer)
Gregory Ginger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:39 PM | ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:27 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:28 PM | Biogen (Issuer)
Murphy Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:29 PM | Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
9:24 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
8:13 PM | Biogen (Issuer)
Rowinsky Eric K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:56 PM | ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:00 PM | Biogen (Issuer)
Izzar Rachid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:01 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:03 PM | Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:04 PM | Biogen (Issuer)
Murphy Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:06 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:14 PM | Biogen (Issuer)
Gregory Ginger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:07 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:07 PM | Biogen (Filed by)
Denali Therapeutics Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
6:11 PM | Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
| Form SC 13G/A | |
02/12/2024
10:21 AM | Biogen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/12/2024
10:10 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
9:50 AM | Biogen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:11 PM | Biogen (Issuer)
Izzar Rachid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:12 PM | Biogen (Issuer)
Grogan Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:14 PM | Biogen (Issuer)
Gregory Ginger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:16 PM | ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
6:56 PM | Biogen (Issuer)
Viehbacher Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
6:59 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:01 PM | Biogen (Issuer)
Murphy Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:03 PM | Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:06 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:08 PM | Biogen (Issuer)
Keeney Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
02/05/2024
5:38 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
9:44 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:34 PM | Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:35 PM | Biogen (Issuer)
Murphy Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:36 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:27 PM | ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:30 PM | Biogen (Issuer)
Gregory Ginger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:31 PM | Biogen (Issuer)
Izzar Rachid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:33 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:52 PM | Biogen (Issuer)
Patolawala Monish D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2023
4:02 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:36 PM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
9:06 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
6:02 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
4:15 PM | Biogen (Issuer)
Grogan Jane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/28/2023
4:25 PM | Biogen (Filer)
| Form 8-K/A | |
09/28/2023
4:30 PM | Biogen (Reporting)
Biogen MA Inc. (Reporting)
SANGAMO THERAPEUTICS, INC (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
3:38 PM | Biogen (Filed by)
REATA PHARMACEUTICALS INC (Subject)
| Form SC 13D/A | |
09/26/2023
4:25 PM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
5:06 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:08 PM | Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
10:23 AM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
3:36 PM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
6:00 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
6:02 AM | Biogen (Filer)
| Form DEFA14A | |
07/28/2023
6:11 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
6:13 AM | Biogen (Filer)
| Form DEFA14A | |
07/25/2023
6:03 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
4:33 PM | Biogen (Issuer)
Singhal Priya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:35 PM | Biogen (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:37 PM | Biogen (Issuer)
Izzar Rachid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
2:37 PM | Biogen (Subject)
Singhal Priya (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:24 PM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
6:00 PM | Biogen (Issuer)
Freire Maria C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:01 PM | Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:03 PM | Biogen (Issuer)
LANGER SUSAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/28/2023
6:04 PM | Biogen (Issuer)
LANGER SUSAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:05 PM | Biogen (Issuer)
Mantas Jesus B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:06 PM | Biogen (Issuer)
Rowinsky Eric K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:10 PM | Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:59 PM | Biogen (Issuer)
DORSA CAROLINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:25 AM | Biogen (Filer)
| Form DEFR14A | |
06/13/2023
6:28 AM | Biogen (Filer)
| Form DEFA14A | |
05/03/2023
8:02 AM | Biogen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2023
7:05 PM | Biogen (Issuer)
Gregory Ginger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:08 PM | Biogen (Issuer)
Keeney Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
4:23 PM | Biogen (Filer)
| Form DEFA14A | |
04/28/2023
4:17 PM | Biogen (Filer)
| Form ARS | |
04/28/2023
12:07 PM | Biogen (Subject)
Gregory Ginger (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
